Building the Back End of Health Care Finance & Access 24/09/2019 by Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 by Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> New Gavi Partnership: Deploying Biometric Technology To Expand Child Vaccine Coverage 07/06/2019 by Divya Schlesinger A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading -> China To Host World Environment Day 2019 On Air Pollution 15/03/2019 by Editorial team As posted by UN Environment in a World Environment Day press release: Nairobi, 15 March 2019 – Today, the head of Chinese delegation, Zhao Yingmin, Vice Minister of Ecology and Environment, and Joyce Msuya, Acting Head of UN Environment, jointly announced that China will host the global World Environment Day celebrations on 5 June 2019 with a theme […] Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 by Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> New Gavi Partnership: Deploying Biometric Technology To Expand Child Vaccine Coverage 07/06/2019 by Divya Schlesinger A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading -> China To Host World Environment Day 2019 On Air Pollution 15/03/2019 by Editorial team As posted by UN Environment in a World Environment Day press release: Nairobi, 15 March 2019 – Today, the head of Chinese delegation, Zhao Yingmin, Vice Minister of Ecology and Environment, and Joyce Msuya, Acting Head of UN Environment, jointly announced that China will host the global World Environment Day celebrations on 5 June 2019 with a theme […] Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Gavi Partnership: Deploying Biometric Technology To Expand Child Vaccine Coverage 07/06/2019 by Divya Schlesinger A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading -> China To Host World Environment Day 2019 On Air Pollution 15/03/2019 by Editorial team As posted by UN Environment in a World Environment Day press release: Nairobi, 15 March 2019 – Today, the head of Chinese delegation, Zhao Yingmin, Vice Minister of Ecology and Environment, and Joyce Msuya, Acting Head of UN Environment, jointly announced that China will host the global World Environment Day celebrations on 5 June 2019 with a theme […] Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
China To Host World Environment Day 2019 On Air Pollution 15/03/2019 by Editorial team As posted by UN Environment in a World Environment Day press release: Nairobi, 15 March 2019 – Today, the head of Chinese delegation, Zhao Yingmin, Vice Minister of Ecology and Environment, and Joyce Msuya, Acting Head of UN Environment, jointly announced that China will host the global World Environment Day celebrations on 5 June 2019 with a theme […] Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 by William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 by David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Surge In Demand Spurs Market-Opening Initiatives In China’s Healthcare Market 20/11/2018 by John Zarocostas SHANGHAI, China - A surge in demand for better healthcare coverage and outcomes and widespread calls for a reduction in high medical treatment costs are driving structural reforms and market-opening initiatives in China's rapidly expanding healthcare market, industry executives, officials and experts have said. The market is forecast to increase from $761 billion in 2017 to nearly $2.4 trillion by 2030. Continue reading -> Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Asia-Pacific: Two Initiatives To Eliminate Malaria Once And For All 13/09/2018 by Leila Ueberschlag For the first time in history, the elimination of malaria is within reach in the Asia Pacific, according to experts. The world is, indeed, witnessing unprecedented progress in the global effort to eliminate the disease. However, some challenges – such as a looming funding gap that threatens critical malaria-elimination – put at risk the recent improvement. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 by Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Posts navigation Older posts